Polyoma virus (Py) diers from other small DNA tumor viruses in not encoding a protein that inactivates p53. The complete Py early region encoding the large Tantigen (PyLT), middle T-antigen (PyMT) and small Tantigen (PyST) will transform primary rodent cells and REF52 cells, but PyMT, the main Py oncogene, by itself will only transform these cells when p53 or ARF is inactivated. We have related Py oncogene cooperation with the eects of the Py T-antigens on the ARF-p53 signaling pathway. PyMT activates an ARF-induced p53-mediated block to cell division explaining the inability of PyMT alone to generate dividing transformed cells. In contrast, in REF52 cells transformed by the whole Py early region (PyREF52), ARF is upregulated but p53 is not activated. Thus PyLT and/ or PyST negates the PyMT-induced ARF-mediated block to cell division by disrupting the signaling pathway from ARF to p53. Although there is no detectable interaction or co-localization of endogenous ARF (nucleoli) and MDM2 (nucleoplasm) in PyREF52 cells, expression of transfected ectopic ARF results in an MDM2/ARF interaction and sequestration of MDM2 into the nucleoli. Sequestration of MDM2 by ARF in the nucleoli is not essential for a p53 response in REF52 cells as activation of Raf in REF52Raf-ER cells results in an ARF-induced p53-mediated cell cycle block in the absence of a detectable ARF-MDM2 interaction. Py may provide new insights into the cellular ARF-p53 signaling pathway. Oncogene (2001) 20, 4951 ± 4960.
Introduction
A number of small DNA tumor viruses depend on the host cell for many of the enzymes required to replicate their DNA and a key step in their infectious cycle is therefore to induce otherwise resting cells to enter S phase. This is usually accomplished by a protein speci®ed by the viral early region (e.g. Adenovirus-E1A, HPV-E7, SV40-large T-antigen) that binds to Rb and stimulates the release of transcription factors, such as E2F1, involved in the expression of S phase speci®c genes (Chellappan et al., 1992) . The cell responds to this unscheduled growth stimulus and/or the activity of other viral proteins by activating its p53 defense gene. To prevent the cell dying before a full complement of newly synthesized virus is produced, viruses usually inhibit the p53-mediated apoptosis pathway. This can be accomplished by viral speci®ed proteins that either inhibit p53 activity through protein ± protein interactions (Adenovirus E1B protein (Yew and Berk, 1992) and the SV40 large T-antigen (Mietz et al., 1992) ) or by promoting the degradation of p53 (HPV E6 protein (Mansur et al., 1995) ).
The mouse polyoma virus (Py) presents a dierent situation. Despite the similarities with SV40 and other polyoma viruses, the early region of the Py genome speci®es three proteins (T-antigens) in overlapping and alternate reading frames, whereas SV40 speci®es only two (large and small T-antigen). The Py large Tantigen (PyLT) is a multifunction nuclear phosphoprotein that is capable of binding to Rb, inducing the cell to enter S phase (Dilworth, 1990) , and immortalizing primary rodent cells (Rassoulzadegan et al., 1983) . Middle T-antigen (PyMT), regarded as the maiǹ oncogene' encoded by the virus, is a membrane associated protein that can bind and activate Src family protein kinases (Courtneidge and Smith, 1983) and serve as a subunit of protein phosphatase 2A (PP2A) (Pallas et al., 1990; Walter et al., 1990) . Small T-antigen (PyST) can also act as a subunit of PP2A and is located in both the nucleus and cytoplasm (Pallas et al., 1990; Walter et al., 1990) . Py is unusual in comparison to the other small DNA viruses in that none of these T-antigens appears to interact directly with the p53 protein (Dilworth, 1990) .
The principle of oncogene cooperation was ®rst demonstrated in experiments showing that the complete Py early region is required for the neoplastic transformation of primary rodent cells, although PyMT alone is capable of transforming most continuous cell lines (Cuzin, 1984; Rassoulzadegan et al., 1982) . Which Py protein(s) is required to cooperate with the PyMT oncogene for the neoplastic transformation of primary rodent cells remains to be elucidated. We have recently shown that the Py early region, encoding all three Py T-antigens, will transform REF52 cells, a line of rat ®broblasts that resemble primary cells in terms of their sensitivity to cooperating oncogenes (Mor et al., 1997) . PyMT alone will not transform REF52 cells or primary mouse embryo ®broblasts but both cell types become sensitive to transformation by PyMT if p53 function is inactivated, indicating that inhibition of p53 activity may play a role in Py-mediated transformation (Mor et al., 1997) . However, REF52 cells transformed by the complete Py early region (PyREF52) express similar low levels of p53 as parental REF52 (Mor et al., 1997) . Thus the presence of the Py T-antigens does not result in either the degradation of p53, as in the case of HPV E6 protein, or the stabilization of p53, as found as a result of binding to SV40 LT. In addition, p53 and its downstream target genes, p21 and MDM2, are induced in a similar fashion in REF52 and PyREF52 cells after DNA damage induced by X-ray and UV treatment (Mor et al., 1997) . These results indicate that neither p53 nor its downstream signaling is inhibited by Py transformation and that inhibition of p53 activation by either PyLT and/or PyST may play a role in Pymediated transformation by a mechanism yet to be determined.
The tumor suppressor genes p53 and Rb are frequent targets for inactivation in carcinogenesis. Rb is involved in the control of the entry of cells into S phase by its phosphorylation and subsequent release of transcription factors including E2F1. P53 is induced in response to a variety of stresses and activation of the p53 pathway can lead to cell cycle arrest or cell death by apoptosis. Stresses such as DNA damage or unscheduled growth signals induced by a number of activated oncogenes can result in the induction of p53. This latter response is usually mediated by the ARF protein (p19 ARF in rodents and p14 ARF in human) (de Stanchina et al., 1998; Palmero et al., 1998; which is speci®ed by the alternative reading frame transcript of the p16INK4A gene in the CDNK2A locus (Duro et al., 1995; Mao et al., 1995; Stone et al., 1995) . MDM2 is a key regulator of p53 activity and can inactivate p53 function by protein ± protein interactions as well as promoting degradation of the p53 protein ± protein (Haupt et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Oliner et al., 1993) . ARF has been postulated to bind to and translocate the MDM2 protein to the nucleolus (Tao and Levine, 1999; Weber et al., 1999) . The sequestration of MDM2 by ARF is thought to block the inhibition of p53 function by MDM2 and thus increase p53 activity.
In the present work we have studied the eect of Py on ARF, the upstream regulator of p53, in REF52 cells. We have asked whether and how the Py Tantigens impact on the ARF pathway, since interference with ARF would provide an alternative mechanism for suppression of a p53 response during viral infection. We ®nd that the PyMT oncogene alone induces the expression of ARF resulting in a p53-mediated block to cell division. This appears to explain the inability of PyMT by itself to generate dividing transformed REF52 cells. In PyREF52 cells, transformed by the complete Py early region specifying all three Py T-antigens, ARF is also present but its ability to signal to p53 is impaired and there is no block to cell division. These results provide an explanation for a mechanism involved in Py oncogene cooperation.
Results
PyMT activates an ARF-induced p53-mediated block to cell division in REF52 cells
We previously reported that ectopic expression of PyMT in REF52 cells has a cytostatic or cytocidal eect, based on the inability to isolate neomycinresistant colonies after co-transfection of an expression vector containing a neomycin resistance gene and a construct containing PyMT (Mor et al., 1997) . As many oncogenes are reported to induce ARF, resulting in p53-dependent apoptosis or cell cycle arrest, it was of interest to determine if the induction of ARF by PyMT might explain its inability to generate dividing transformed REF52 cells. A retrovirus containing PyMT (pBabeNeoPyMT) was used to introduce PyMT into REF52 cells and 30 h after infection the cells were ®xed and stained for PyMT, ARF, MDM2 and p53. The cells expressing PyMT, detected as membrane staining, also stained positively for ARF in the nucleoli ( Figure 1a ) and p53 in the nucleus (Figure 1c ). In the PyMT expressing cells MDM2 was not found to be sequestered into the nucleoli by ARF (Figure 1b) . No stable neomycin-resistant transformed colonies could be isolated, in agreement with the notion that the expression of PyMT in the absence of the other Py Tantigens is incompatible with continued cell division.
We have previously shown that PyMT alone will not transform p53 +/+ mouse embryo ®broblasts, but will transform p53 7/7 mouse embryo ®broblasts (Mor et al., 1997) . We sought to determine the eect of ARF on the transforming ability of PyMT. ARF 7/7 and ARF +/+ mouse embryo ®broblasts cells were infected with a retrovirus containing PyMT (pBabeNeoPyMT) and dierent numbers of infected cells were assessed for their ability to generate colonies of transformed cells. As shown in Figure 1d colonies of transformed cells were generated from the PyMT infected ARF 7/7 cells but not from the PyMT infected ARF +/+ mouse embryo ®broblasts. As PyMT will transform mouse embryo ®broblasts in the absence of either p53 (Mor et al., 1997) or ARF (Figure 1d ), the PyMT activation of an ARF-induced p53-mediated block to cell division can explain the inability of PyMT, by itself, to generate dividing transformed cells.
ARF is activated in the absence of p53 up-regulation in PyREF52 cells
The presence of PyMT alone in REF52 cells results in the induction of an ARF-induced p53-mediated block to cell division (see above). Thus it was of interest to determine if Py transformed REF52 cells (PyREF52), which contain PyST and PyLT in addition to PyMT, and divide quite robustly, also express ARF. In PyREF52 cells p53 is not increased and the p53 responses to DNA damage and the induction of genes downstream of p53 are intact (Mor et al., 1997) . ARF expression was easily detected at both the RNA (Figure 2a ) and protein ( Figure 2b ) levels in three dierent clonal isolates of PyREF52 cells examined.
In order to see if Py transformation selected REF52 cells with mutated ARF, which could no longer activate p53, ARF cDNAs generated by RT ± PCR were cloned from three independent PyREF52 isolates and REF52 cells. Sequence analysis of all three PyREF52 ARF cDNAs were identical to the REF52 ARF cDNA sequence and the sequence previously published for rat ARF (Swaord et al., 1997) . In addition, no complexes between the Py T-antigens and ARF or MDM2 could be demonstrated by Western Figure 1 PyMT induces ARF in the nucleoli and p53 in the nucleus of REF52 cells and transforms ARF 7/7 mouse embryo ®broblasts. In (a ± c) REF52 cells were infected with a PyMT containing retrovirus (pBabeNeoPyMT). After 30 h the infected cells were ®xed in 50% methanol/50% acetone and then stained for ARF (R562), PyMT (PAb762), MDM2 (SMP14) and p53 (CM-5). (a) ARF is stained red (Texas red) and is located in the nucleoli and PyMT is stained green (FITC) (1006 magni®cation). Uninfected REF52 cells do not contain ARF in the nucleoli (see Figure 3 ). (b) ARF is stained red (Texas red) and is located in the nucleoli and MDM2 is stained green (FITC) and is located in the nucleoplasm (1006 magni®cation). (c) p53 is stained red (Alexa 594) and is located in the nucleus and the membrane associated PyMT is stained green (Alexa 488) (206 magni®cation). (d) Black6/129 ARF 7 / 7 and ARF +/+ primary mouse embryo ®broblasts cells (a kind gift of Emmy Verschuren) were infected with a retrovirus containing PyMT (pBabeNeoPyMT) and dierent numbers of infected cells were assessed for their ability to generate dense colonies of morphologically transformed cells. The cells were stained with 0.5% crystal violet (in 10% methanol) after 9 days
Figure 2 ARF is induced in PyREF52 cells but does not interact with MDM2. A Northern blot (a) and a Western blot (b) to determine the mRNA and protein levels of ARF in three isolates of PyREF52 cells compared to non-transformed REF52 cells. PyBREF52, PyDREF52 and PyEREF52 are three independently isolated Py transformed REF52 clones previously described (Mor et al., 1997) . DN-REF52 cells (expressing dominant negative p53) (Mor et al., 1997) were used as a positive control for the Northern blot as they contain abundant ARF as a result of loss of functional p53 (Kamijo et al., 1997; Quelle et al., 1995; Stott et al., 1998) . (c) REF52 and PyREF52 cells were lysed and MDM2 was immunoprecipitated using SMP14 antibody and the immunoprecipitated proteins were run on SDS-polyacrylamide gels. The Western blots were probed for MDM2 (2A10) or ARF (MLOM5). CON is a control lysate of DN-REF52 cells which is ARF positive to indicate the position ARF runs on the gel analysis after either immunoprecipitation of the Py Tantigens or after transfection of GST-ARF into REF52 and PyREF52 cells and isolation of the transfected GST-ARF by its binding to glutathione-sepharose beads via the GST motif (data not shown). These results strongly suggest that the Py T-antigens do not interact directly with ARF or MDM2 proteins to block it signaling to p53.
Interaction and co-localization of endogenously expressed ARF and endogenous MDM2 is not detected in PYREF52 cells MDM2 is a key regulator of p53 and can inactivate p53 function by direct binding as well as promoting degradation of the p53 (Haupt et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Oliner et al., 1993) . ARF is thought to activate p53 by binding to MDM2 and blocking its inhibition of p53 function (Honda and Yasuda, 1999; Kurokawa et al., 1999; Pomerantz et al., 1998; Stott et al., 1998) . Recently a number of studies have demonstrated that ARF is localized to the nucleoli (Tao and Levine, 1999; Weber et al., 1999; Zhang and Xiong, 1999) . ARF, especially when ectopically over-expressed, can bind to MDM2 and translocate it to the nucleolus (Tao and Levine, 1999; Weber et al., 1999) . The sequestration of MDM2 by ARF is thought to block its inhibition of p53 function and thus facilitate accumulation of active p53 and consequently the induction of p53 downstream genes (Weber et al., 1999) .
ARF is present in PyREF52 cells (Figure 2a ,b) but p53 is not (Mor et al., 1997) . Similar to REF52 cells infected with PyMT, MDM2 and ARF were not found to be co-localized in the nucleoli of PyREF52 cells (Figure 3) . ARF was barely detectable in REF52 cells but was easily detected in PyREF52 cells and was localized to the nucleoli (Figure 3) . In both REF52 and PyREF52 cells the endogenous MDM2 was found to be located in the nucleoplasm. The apparent lack of an ARF/MDM2 complex in PyREF52 cells was con®rmed by immunoprecipitation with an anti-MDM2 antibody followed by Western blotting (Figure 2c ). Thus, in PyREF52 cells the endogenous MDM2 is not found to interact with or to co-localize with the endogenous ARF in the nucleoli (Figure 3) . The abundant MDM2 present in the nucleoplasm could be available to associate with and down regulate functional p53 in PyREF52 cells.
We have also observed that in a Py transformed mouse BALB/c 3T3 cell line, which contains functional wild type non-activated p53, the endogenous ARF is abundant and located in the nucleolus and does not colocalize with the endogenous nucleoplasmic MDM2, which is located in the nucleoplasm (as in Figure 3 ). In these Py transformed mouse cells the p53 can also be activated by DNA damage. Thus the presence of abundant ARF and the inability of ARF to signal to p53 seems to be a general property of Py transformed cells and not restricted to PyREF52 cells.
Ectopically expressed rat ARF can bind to and co-localize with endogenous MDM2 in REF52 and PyREF52 cells
We sought to see what eect the presence of high amounts of ectopically expressed rat ARF would have on the localization of the endogenous MDM2 in REF52 and PyREF52 cells. In order to identify the transfected cells, a GFP plasmid (pEGFP-F) was cotransfected with the rat ARF expressing DNA Figure 3 Immuno¯uorescence staining of REF52 and PyREF52 cells for ARF and MDM2. REF52 cells (top) and PyREF52 cells (bottom) were ®xed in 50% methanol/50% acetone and then stained for ARF (R562) and MDM2 (SMP14). ARF is stained red (Texas red) and MDM2 is stained green (FITC) construct (pCDNA3ARF). This is especially important for the PyREF52 cells, in which the anti-ARF antibody used could not distinguish ectopically expressed ARF in the presence of the pre-existing abundant endogenous ARF. In both the transfected REF52 and PyREF52 cells ectopically expressed rat ARF accumulated within the nucleoli, and in both cell types the endogenous MDM2 was now found to be colocalized with the ARF in the nucleoli (Figure 4a ). Western analysis of immunoprecipitated MDM2 demonstrates that ARF is now co-immunoprecipitated with the MDM2 in the transfected cells (Figure 4b) .
We also sought to determine after ecotropic expression of ARF whether a complex between MDM2 and ARF could also be detected by isolation via the ARF moiety. Due to our inability to obtain an antibody against rat ARF that could be used in an immunoprecipitation reaction, a GST-ARF fusion protein was used as it could be isolated by its binding to glutathione-sepharose beads via the GST motif. The ability of ectopically over-expressed GST-ARF to bind to MDM2 was assessed 30 h after transfection. In both REF52 and PyREF52 cells a GST-ARF-MDM2 complex was easily detected (Figure 4c ). These results show that in the presence of high levels of ectopically expressed rat ARF the endogenous MDM2 expressed in REF52 and PyREF52 cells can bind to ARF and be sequestered by ARF into the nucleoli. In addition these results show that the MDM2 in REF52 cells is not restricted in its ability to bind to ARF.
Raf induces ARF, p53 and a cell cycle block in REF52 in the absence of sequestration of MDM2 by ARF into the nucleoli To address the question whether the inability of ARF to signal to p53 in PyREF52 cells was a phenomenon characteristic of REF52 cells or due to the presence of the Py T-antigens, the properties of REF52 cells containing a tamoxifen inducible Raf oncogene were analysed. REF52 cells were infected with a Raf-ER retrovirus containing a selectable neomycin marker. Pools of neomycin resistant colonies (REF52Raf-ER cells) were analysed untreated or following treatment with 100 nM tamoxifen to activate the Raf oncogene. Western blot analysis of two pools (pool 1 and pool 2) of REF52Raf-ER cells treated with tamoxifen for 48 h revealed an induction of ARF, p53 and the p53 inducible MDM2 gene (Figure 5a ), indicating that in REF52 cells the Raf oncogene induces ARF which activates p53 and results in an increase in the levels of p53 downstream genes. The tamoxifen treated Immuno¯uorescence staining of REF52 and PyREF52 cells transfected with pCDNA3ARF and a construct expressing green uorescent protein (pEGFP-F). Forty-eight hours after transfection the cells were ®xed in 50% methanol/50% acetone and then stained for ARF (R562) and MDM2 (SMP14). Green¯uorescence is GFP and red¯uorescence is ARF (Texas red) or MDM2 (Alexa 546). (b) MDM2 was immunoprecipitated using SMP14 antibody from REF52 and PyREF52 cells after transfection with either rat ARF (pCDNA3ARF) or empty vector (pCDNA3EV). The immunoprecipitated proteins were run on SDS-polyacrylamide gels, immunoblotted and probed for MDM2 (2A10) or ARF (MLOM5). (c) REF52 and PyREF52 cells were transfected with rat GST-ARF or GST empty vector (GST-EV) DNA. Thirty hours after transfection the GST-ARF and GST (GST-EV) proteins were pulled down from the transfected cell extracts with glutathione sepharose beads and the immunoprecipitated proteins were run on SDS-polyacrylamide gels. The Western blots were probed for GST (Z5) or MDM2 (2A10) REF52Raf-ER cells were arrested in the G 1 and G 2 stages of the cell cycle (data not shown).
Immuno¯uorescence staining of the tamoxifen treated REF52Raf-ER cells did not reveal the presence of a MDM2/ARF complex in the nucleoli. The induced endogenous ARF was located in the nucleoli and the endogenous MDM2 was found in the nucleoplasm (Figure 5b) . Furthermore, no MDM2/ ARF complexes were detected after immunoprecipitation of extracts of REF52Raf-ER cells for 2 h at 48C with anti-MDM2 antibody SMP14 (Figure 5c ). This result is similar to that observed in PyMT infected REF52 cells, where there was no co-localization of endogenous ARF and endogenous MDM2 in the nucleoli, in the presence of an ARF-induced activation of p53 (Figure 1 ). Thus in REF52 cells sequestration of MDM2 into the nucleoli by ARF is not necessary for the activation of p53.
Discussion
Py is unusual with respect to the other small DNA viruses in that none of its early region proteins have been found to interact directly with the p53 protein (Dilworth, 1990) . It would be expected that Py, like most other small DNA viruses, would suppress the generation of active p53. The main focus of the present research is to determine the strategy Py employs to modulate p53 activity. This work has assessed the eect of Py on ARF, an upstream regulator of p53. When ARF levels are high p53 is normally induced and cells either die by apoptosis or are prevented from dividing as the result of a cell cycle arrest. In dividing cells that contain high amounts of ARF, p53 is usually inactivated or absent (Kannan et al., 2000; Quelle et al., 1995; Stott et al., 1998) . PyREF52 cells contain both high levels of ARF and an active p53 but are not Figure 5 Raf induces ARF, p53 and MDM2 but endogenous ARF and MDM2 do not interact or co-localize following induction of ARF by Raf in REF52Raf-ER. REF52 cells were infected with LXSNDRaf-1:ER retrovirus (containing a G418 resistance gene) so that the expression of Raf could be controlled by the addition of tamoxifen. After selection with G418 two pools of G418-resistant cells (REF52Raf-ER cells) were analysed. Tamoxifen (100 nM) was added to REF52Raf-ER cells and 48 h following the addition of tamoxifen the cells were assayed. (a) Western blot of lysates from REF52Raf-ER cells demonstrating that activation of the expression of Raf induces ARF (MLOM5), p53 (R-19) and MDM2 (2A10) in REF52 cells. (b) Immuno¯uorescence staining of REF52Raf-ER cells. Forty-eight hours after the addition of tamoxifen cells were ®xed in 50% methanol/50% acetone and then stained for ARF (R562) and MDM2 (SMP14). ARF is stained red (Texas red) and MDM2 is stained green (FITC). (c) Forty-eight hours after addition of tamoxifen REF52Raf-ER cells were lysed and MDM2 was immunoprecipitated using SMP14 antibody and the immunoprecipitated proteins were run on SDS-polyacrylamide gels. The Western blots were probed for MDM2 (2A10) or ARF (MLOM5) inhibited in their division. Our results indicate that Py disrupts the signaling pathway from ARF to p53 so that although ARF is activated p53 is not upregulated. A model to explain our results is presented in Figure 6 . We postulate that the presence of PyMT alone activates ARF (Figure 1a) , which induces the upregulation of p53 (Figure 1c ) resulting in a block to cell division via a cell cycle arrest or apoptosis. This would explain the inability of PyMT alone to transform primary rodent and REF52 cells unless p53 is inactivated (Mor et al., 1997) . We also show that PyMT alone can morphologically transform early passage ARF-null mouse embryo ®broblasts ( Figure  1d ). This result reinforces the notion that the PyMTinduced block to cell division is via the ARF signaling pathway (Figure 6 ).
In Py transformed cells containing all three Py Tantigens there is no block to cell division. In these PyREF52 cells PyMT-induced ARF levels are high but p53 levels are low. The p53 in PyREF52 is still functional and can be activated upon DNA damage (Mor et al., 1997) . We postulate that this is because PyLT and/or PyST abrogate the ARF signaling to p53 (Figure 6 ). Thus, Py is similar to other small DNA viruses in inhibiting p53 function, but diers from the other viruses in that it does not inhibit p53 function directly. Py somehow targets the ARF signaling pathway to p53, so that p53 is not upregulated when ARF is activated (Figure 6 ). One possible mechanism by which the ARF-p53 pathway could be disrupted is via PyST. PyST can act as a subunit of the protein phosphatase 2A (PP2A) (Pallas et al., 1990; Walter et al., 1990) and modify its speci®city towards dierent substrates. The activity of many proteins is regulated by phosphorylation, including p53 (Meek, 1998) and MDM2 (Mayo et al., 1997) , and aberrant dephosphorylation could have a profound eect on their activity. The phosphorylation status of ARF remains to be elucidated. Thus, PyST could cause or prevent a critical modi®cation to one or more proteins in the ARF-MDM2-p53 pathway, resulting in the inhibition of the activation of p53.
It is also possible that PyLT may modulate the expression of cellular genes that are involved in or inhibit the ARF signaling pathway to p53. By its ability to bind to Rb PyLT can cause the release of a number of transcription factors including E2F1, which can activate or repress cellular genes. In addition, by binding to cellular DNA sequences similar to those sequences present in the Py origin of DNA replication, PyLT could possibly activate or repress important cellular genes that disrupt the ARF-p53 pathway. It is also possible that signaling to p53 by ARF could be inhibited by a combination of the activities of both PyST and PyLT. The inhibition of ARF signaling to p53 by PyLT and/or PyST provides a basis for oncogene cooperation with the main Py oncogene, PyMT. PyMT alone, although capable of transforming many continuous cell lines, cannot transform primary rodent cells or REF52 cells as it induces a p53 block of cell division via activation of ARF. However, in the presence of PyLT and/or PyST, which negate the ARF signal to p53, the expression of PyMT results in dividing transformed cells.
Recently a number of studies have reported that ARF accumulates in nucleoli of cells and sequesters MDM2 into the nucleoli (Tao and Levine, 1999; Weber et al., 1999) . One of the functions of MDM2 is to regulate the levels and activity of p53. MDM2 can prevent p53 mediated transcriptional activity by binding to p53 (Oliner et al., 1993) and, in addition, MDM2 can mediate the degradation of p53 via the proteosome (Haupt et al., 1997; Kubbutat et al., 1997) . MDM2 sequestration in the nucleoli could block this MDM2 mediated inhibition of p53 function (Weber et al., 1999) .
Infection of REF52 cells with PyMT resulted in an induction of endogenous ARF and a subsequent p53-mediated block to cell division. In these cells endogenous MDM2 was not sequestered to the nucleoli by the endogeneous ARF (Figure 1b) . Similarly, following Raf activation in REF52Raf-ER cells, endogenous ARF was induced and also accumulated in the nucleoli and endogenous MDM2 was Figure 6 A model to explain how Py evades an ARF induced p53 response. p53 is involved in protecting cells against cellular stresses including DNA damage and unscheduled growth responses as a result of activated oncogenes. Induction of p53 can lead to growth arrest or apoptosis. The activation of the p53 pathway by an inappropriate growth signal is mediated by ARF. A number of small DNA tumor viruses specify proteins that target and inactivate p53, such as SV40LT, HPV E6 and Adenovirus E1B 55 Kd, or block p53-induced apoptosis (E1B 19 Kd). Py is unusual in respect to the other DNA viruses in that none of its early region proteins bind to p53 and it employs a dierent strategy to block p53 activation. PyMT, as a number of other activated oncogenes, induces ARF and consequently p53, resulting in either apoptosis or cell cycle arrest. PyMT alone can transform cells in which either p53 or ARF is inactivated, or in the presence of the other Py T-antigens. This work has shown that Py targets the ARF signaling pathway to p53. Following the induction of ARF by the PyMT oncogene, PyST and/or PyLT inhibit the signaling pathway from ARF to p53 so that even though abundant amounts of ARF are present p53 is not activated located predominately in the nucleoplasm (Figure 5b ). Raf activation resulted in not only an induction of ARF but also in the activation of p53 (Figure 5a ) and a cell cycle block. Thus, in PyMT infected REF52 cells and REF52Raf-ER cells, absence of ARF-mediated MDM2 sequestration into the nucleoli is not sucient to block ARF signaling to p53. Likewise an ARF/ MDM2 complex could not be detected in PyREF52 cells (Figure 2c ) and immuno¯uorescence analysis showed that in PyREF52 cells the endogenous wildtype ARF was induced and accumulated in the nucleolus and the endogenous MDM2 was located predominately in the nucleoplasm (Figure 3) . However, no such activation of p53 was seen in PyREF52 cells (Mor et al., 1997) , which also contain high levels of ARF (Figures 2 and 3) .
Most previous reports of MDM2 sequestration by ARF were determined following expression of high levels of exogenous ARF and MDM2 proteins (Tao and Levine, 1999; Weber et al., 1999; Zhang and Xiong, 1999) . In the case of both the PyREF52 and the REF52Raf-ER cells (where sequestration of MDM2 by ARF is not observed) the ARF and MDM2 proteins were endogenous to the cell and expressed at a lower level than ectopically expressed proteins. In agreement with previous reports, complete translocation of MDM2 into the nucleoli by ARF in REF52 and PyREF52 was demonstrated in the presence of high levels of ectopically expressed ARF generated after transfection (Figure 4b ). Thus the MDM2 in the REF52 cell lines is not impaired in its ability to associate with ARF.
Based on our observations we cannot assign a major role of MDM2 in the activation of the ARF-p53 pathway ( Figure 6 ). It is possible that MDM2 is not usually involved in the ARF-p53 pathway at least in REF52 cells. However, because we cannot detect an ARF\MDM2 complex it does not mean that such an interaction does not take place. The induction of p53 by ARF may not require the stable interaction of ARF with MDM2 and sequestration of MDM2 to the nucleoli. It is a possibility that ARF could prevent MDM2 mediated inhibition of p53 function by a mechanism not involving translocation of MDM2. ARF could aect the inhibition of p53 activity by MDM2 by both direct and indirect mechanisms. A direct but transient interaction of ARF and MDM2 (which may also involve the interaction of other proteins) could result in a modi®cation of MDM2 such that it is no longer capable of interacting with and/or degrading p53. In such a model ARF would not be required in the complex following modi®cation of MDM2. The small amount of ARF located in the nucleoplasm present in such a transient complex could be below the level of detection. In an indirect fashion, ARF may induce/modify another protein, e.g. p300 or MDMX, which could bind to and/or block the ability of MDM2 to inactivate p53.
A second possibility is that only a small amount of MDM2, possibly a subclass (e.g. post-translationally modi®ed) is the form of MDM2, which interacts with p53. A small amount of endogenous ARF binding to the`active' species of MDM2 could take place in the nucleoplasm and be sucient to block the inhibitory eect of MDM2 on p53 function. Again the small amount of ARF located in the nucleoplasm during such an interaction could be below the level of detection.
Although such theories may explain the ARF activation of p53 in PyMT infected REF52 cells and REF52Raf-ER cells in the absence of MDM2 sequestration by ARF, they do not shed light on the inability of ARF to upregulate p53 in PyREF52 cells. We are presently attempting to identify which Py protein(s) are involved in the inhibition of the ARF pathway by their ability to overcome the PyMT induced ARF block to cell division. Preliminary results indicate that REF52 can be transformed by PyST in combination with PyMT and these transformed cells contain high amounts of ARF (located in the nucleoli) and low p53 levels. We are presently trying to identify a mechanism for the inhibition of the pathway by looking for Py induced alterations of ARF posttranslational modi®cations, ARF complexes and MDM2/p53 interactions in PyREF52 cells, in which ARF signaling to p53 is inhibited, in comparison to REF52 cells, in which ARF signaling leads to a cell cycle block/apoptosis (e.g. REF52Raf-ER cells). Following the induction of ARF by the PyMT oncogene, there is a defect in the signaling of ARF to p53, which appears to be mediated by PyST and/or PyLT. Identi®cation of this mechanism should shed new light on ARF signaling to p53 in both normal and tumor cells.
Materials and methods
Cell culture, plasmids and transfection REF52 is an established rat embryonic ®broblast cell line and early passage cells were obtained from Cold Spring Harbor Laboratories. REF52 cells containing the MLV ecotropic receptor were a kind gift from Dr Scot Lowe and were used for most retrovirus infections. PyREF52 cells were established by transfection of the complete Py genome in pAT153 and DN-REF52 cells were established by transfection of pBabepuro-p53 302-390 (Mor et al., 1997) . REF52Raf-ER cells were generated by infection of REF52 cells with LXSNDRaf-1:ER retrovirus generated from the GP+E producer cell line (Lloyd et al., 1997) obtained from the laboratory of Dr Hartmut Land. The pBabeNeoPyMT retrovirus was obtained from the JS169 producer cell line, which was a kind gift of Dr Parmjit Jat. Unfortunately infection rates of REF52 cells with retroviruses containing PyMT were not very ecient, with a maximum of only 15% of the cells being infected at any one time.
All cells were routinely cultured in Dulbecco's modi®ed Eagle medium supplemented with 10% fetal bovine serum, 100 mg/ml penicillin and 100 mg/ml streptomycin. For DN-REF52 the medium was also supplemented with 1.25 mg/ml puromycin and for REF52Raf-ER the medium was supplemented with 0.8 mg/ml G418.
GST-ARF was generated by placing the ARF PCR product from PyREF52 into pEF.GST plasmid (a gift from R Treisman) to the GST sequence. ARF was cut out of GST-ARF as an EcoRI/XbaI fragment and placed in pCDNA3-Neo (Invitrogen) to create pCDNA3-ARF. pEGFP-F was purchased from ClonTech.
All transfections were carried out using 2 mg plasmid DNA transfected into 6 cm dish using Eectene (Qiagen).
Sequencing of ARF
ARF was isolated from REF52 and three isolates of PyREF52 by PCR and sequenced using an ABI 377 DNA sequencer.
Western analysis of protein
Cells were lysed directly in NP-40 lysis buer (150 mM NaCl, 50 mM Tris-HCl pH 8.0, 5 mM EDTA pH 8.0, 1% NP-40) and protein concentration was determined using the DC Protein Assay (BioRad). Fifty microgram protein samples were loaded onto SDS-polyacrylamide gels. After electrophoresis, proteins were transferred to PVDF membrane (NEN) and the membrane was blocked in 5% milk in PBS for 1 h at room temperature. The membrane was probed for ARF with either MLOM5 or R562 (AbCam). MLOM5 is a rabbit polyclonal antibody generated against a C-terminal synthetic peptide of rat ARF conjugated to keyhole limpet hemocyanin. The synthetic peptide used was NH 2 -VSTLLRWERFPGHRQ. The speci®city of the MLOM5 and R562 (AbCam) antibodies against rat ARF was shown by their ability to interact with a 19 Kd band in extracts of DN-REF52 cells, which lack a functional p53 and contain high amounts of ARF mRNA (see Figure 2) , and the absence of a 19 Kd protein in extracts of Rat-1 cells which contain little or no ARF mRNA even in the presence of a dominantnegative p53. R562 (AbCam) also detected ARF in the nucleoli of REF52 cells by immuno¯uorescence (see below). The membranes were also probed for MDM2 (2A10, gift from A Levine), GST (Z5, Santa Cruz), Py T-Ags (C1, ICRF), p21 WAF1 (SX118, Pharmingen) and p53 (R-19, Santa Cruz). The membranes were then incubated with peroxidaseconjugated rabbit, rat, goat or mouse immunoglobulins (Amersham) as appropriate. Detection was performed using ECL (Amersham) according to the manufacturer's protocol.
Immunoprecipitation of proteins
Cells were lysed with NP-40 lysis buer and the resulting lysate was mixed with glutathione-sepharose beads (Pharmacia) to pull down GST/GST-ARF; SMP14 antibody (against MDM2) directly conjugated to agarose beads (Santa Cruz) or with PAb762 antibody (against Py ST, MT and LT, a gift from S Dilworth) bound to protein A beads (Pharmacia). The lysates were incubated at 48C for 2 h. The beads were washed six times with NP-40 lysis buer and then run on SDS-polyacrylamide gels. The proteins were Western blotted and probed for GST, Py T-Ags, MDM2 or ARF.
Northern analysis of RNA
Total RNA was prepared using 1 ml Trizol (Gibco-BRL) reagent/10 6 cells according to the manufacturer's instructions. Twenty microgram RNA was electrophoresed on 1.4% formaldehyde agarose gel and transferred to Hybond N + nitrocellulose membrane (Amersham). The random priming method (Feinberg and Vogelstein, 1984) was used to label 50 ng probe DNA. The membrane was prehybridized using RapidHyb buer (Amersham) for 1 h at 658C, prior to addition of probe directly to the prehybridization solution. Hybridization was carried out at 658C for 2 h. The membrane was washed once at room temperature with 26 SSC; 0.1% SDS for 20 min and then twice at 658C with 0.2% SSC; 0.1% SDS for 20 min. Autoradiography was carried out overnight at 7708C.
Immunofluorescence
Cells were grown on glass cover slips and ®xed in 50% methanol/50% acetone at 7208C for 10 min. The cells were blocked for 1 h at room temperature with 20% normal goat serum (Jackson ImmunoResearch) in PBS. Cells were stained for ARF with R562 (AbCam) and p53 with CM-5 (NovaCastra Laboratories) followed by Texas-red-conjugated rabbit immunoglobulins (Jackson ImmunoResearch), for MDM2 with SMP14 (NeoMarkers) followed by¯uorescein isothyocyanate (FITC)-conjugated mouse immunoglobulins (Jackson ImmunoResearch) or Alexa546-conjugated mouse immunoglobulins (Molecular Probes) and for GST with Z5 (Santa Cruz) followed by Texas-red-conjugated rabbit immunoglobulins (Jackson ImmunoResearch). Cells were counter stained with DAPI (Sigma) and then analysed on an Axioplan-Z confocal microscope (Zeiss) with Zeiss LSM-510 software.
Note added in proof
After the completion of this work two papers were published which also failed to detect sequestration of MDM2 into the nucleoli by ARF. In one (Lin and Lowe, 2001 ) endogenous ARF failed to sequester endogenous MDM2 into the nucleoli in primary mouse embryo cells and in the other (Llanos et al., 2001 ) ARF failed to sequester MDM2 into the nucleoli in established human U2OS cells.
